Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Yalin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Immunity|March 9, 2022
Single-cell immunology: Past, present, and futureFlorent Ginhoux, Adam Yalin, Charles Antoine Dutertre, et al.
Science Immunology|March 3, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacyNoy Cohen Saban, Adam Yalin, Tomer Landsberger, et al.
Immunity|May 4, 2021
Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulationAdelle P McFarland, Adam Yalin, Shuang-Yin Wang, et al.
Nature Cancer|October 27, 2022
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Nature Cancer|November 14, 2022
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Cell|August 14, 2020
Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in CancerYonatan Katzenelenbogen, Fadi Sheban, Adam Yalin, et al.
Cell|November 20, 2025
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapyMichelle von Locquenghien, Pascale Zwicky, Ken Xie, et al.
Cancer Discovery|September 27, 2023
Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic BoundaryIdo Yofe, Tamar Shami, Noam Cohen, et al.
Nature Cancer|March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocolsOren Barboy, Akhiad Bercovich, Hanjie Li, et al.
Cell|April 5, 2022
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in sclerodermaChamutal Gur, Shuang-Yin Wang, Fadi Sheban, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Immunity|March 9, 2022
Single-cell immunology: Past, present, and futureFlorent Ginhoux, Adam Yalin, Charles Antoine Dutertre, et al.
Science Immunology|March 3, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacyNoy Cohen Saban, Adam Yalin, Tomer Landsberger, et al.
Immunity|May 4, 2021
Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulationAdelle P McFarland, Adam Yalin, Shuang-Yin Wang, et al.
Nature Cancer|October 27, 2022
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Nature Cancer|November 14, 2022
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, et al.
Cell|August 14, 2020
Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in CancerYonatan Katzenelenbogen, Fadi Sheban, Adam Yalin, et al.
Cell|November 20, 2025
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapyMichelle von Locquenghien, Pascale Zwicky, Ken Xie, et al.
Cancer Discovery|September 27, 2023
Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic BoundaryIdo Yofe, Tamar Shami, Noam Cohen, et al.
Nature Cancer|March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocolsOren Barboy, Akhiad Bercovich, Hanjie Li, et al.
Cell|April 5, 2022
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in sclerodermaChamutal Gur, Shuang-Yin Wang, Fadi Sheban, et al.
Pageof 1